TOP

Minireview

Split Viewer

Mol. Cells 2012; 33(3): 217-222

Published online February 28, 2012

https://doi.org/10.1007/s10059-012-2297-y

© The Korean Society for Molecular and Cellular Biology

The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases

Je-Min Choi1,2,*, and Alfred L.M. Bothwell3,*

1Department of Life Science, Research Institute for Natural Sciences, Hanyang Universtiy, Seoul 133-791, Korea, 2Hanyang Biomedical Research Institute, Hanyang Universtiy, Seoul 133-791, Korea, 3Department of Immunobiology, Yale University School of Medicine, CT 06520, USA

Correspondence to : *Correspondence: jeminchoi@hanyang.ac.kr (JMC); alfred.bothwell@yale.edu (ALMB)

Received: December 29, 2014; Revised: January 22, 2012; Accepted: February 9, 2012

Abstract

Members of the nuclear receptor superfamily function as transcription factors involved in innate and adaptive im-munity as well as lipid metabolism. These highly conser-ved proteins participate in ligand-dependent or -indepen-dent regulatory mechanisms that affect gene expression. Peroxisome proliferator-activated receptors (PPARs), which include PPAR?, PPAR?/?, and PPAR?, are a group of nuclear receptor proteins that play diverse roles in cellular differentiation, development, and metabolism. Each PPAR subfamily is activated by different endogenous and synthetic ligands. Recent studies using specific ligand treatments and cell type-specific PPAR knockout mice have revealed important roles for these proteins in T-cell-related autoimmune diseases. Moreover, PPARs have been shown to regulate T-cell survival, activation, and CD4+ T helper cell differentiation into the Th1, Th2, Th17, and Treg lineages. Here, we review the studies that provide insight into the important regulatory roles of PPARs in T-cell activation, survival, proliferation, differentiation, and autoimmune disease.

Keywords autoimmune disease, nuclear receptor, PPAR, T cell

Article

Minireview

Mol. Cells 2012; 33(3): 217-222

Published online March 31, 2012 https://doi.org/10.1007/s10059-012-2297-y

Copyright © The Korean Society for Molecular and Cellular Biology.

The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases

Je-Min Choi1,2,*, and Alfred L.M. Bothwell3,*

1Department of Life Science, Research Institute for Natural Sciences, Hanyang Universtiy, Seoul 133-791, Korea, 2Hanyang Biomedical Research Institute, Hanyang Universtiy, Seoul 133-791, Korea, 3Department of Immunobiology, Yale University School of Medicine, CT 06520, USA

Correspondence to:*Correspondence: jeminchoi@hanyang.ac.kr (JMC); alfred.bothwell@yale.edu (ALMB)

Received: December 29, 2014; Revised: January 22, 2012; Accepted: February 9, 2012

Abstract

Members of the nuclear receptor superfamily function as transcription factors involved in innate and adaptive im-munity as well as lipid metabolism. These highly conser-ved proteins participate in ligand-dependent or -indepen-dent regulatory mechanisms that affect gene expression. Peroxisome proliferator-activated receptors (PPARs), which include PPAR?, PPAR?/?, and PPAR?, are a group of nuclear receptor proteins that play diverse roles in cellular differentiation, development, and metabolism. Each PPAR subfamily is activated by different endogenous and synthetic ligands. Recent studies using specific ligand treatments and cell type-specific PPAR knockout mice have revealed important roles for these proteins in T-cell-related autoimmune diseases. Moreover, PPARs have been shown to regulate T-cell survival, activation, and CD4+ T helper cell differentiation into the Th1, Th2, Th17, and Treg lineages. Here, we review the studies that provide insight into the important regulatory roles of PPARs in T-cell activation, survival, proliferation, differentiation, and autoimmune disease.

Keywords: autoimmune disease, nuclear receptor, PPAR, T cell

Mol. Cells
Sep 30, 2023 Vol.46 No.9, pp. 527~572
COVER PICTURE
Chronic obstructive pulmonary disease (COPD) is marked by airspace enlargement (emphysema) and small airway fibrosis, leading to airflow obstruction and eventual respiratory failure. Shown is a microphotograph of hematoxylin and eosin (H&E)-stained histological sections of the enlarged alveoli as an indicator of emphysema. Piao et al. (pp. 558-572) demonstrate that recombinant human hyaluronan and proteoglycan link protein 1 (rhHAPLN1) significantly reduces the extended airspaces of the emphysematous alveoli by increasing the levels of TGF-β receptor I and SIRT1/6, as a previously unrecognized mechanism in human alveolar epithelial cells, and consequently mitigates COPD.

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download